GenixPharmaceucticals Corporation (GENX) — Cash Flow Quality Index

Latest as of October 2024: -0.26x

GenixPharmaceucticals Corporation (GENX) has a Cash Flow Quality Index of -0.26x as of October 2024. Operating cash flow of CA$-40.35K is below net income of CA$153.98K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of GenixPharmaceucticals Corporation to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.26x
Operating CF / Net Income

Operating Cash Flow

CA$-40.35K
CAD

Net Income

CA$153.98K
CAD

Data as of

Oct 2024
Most recent filing

GenixPharmaceucticals Corporation Cash Flow Quality Index (2018–2018)

Historical Cash Flow Quality Index for GenixPharmaceucticals Corporation across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GenixPharmaceucticals Corporation investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for GenixPharmaceucticals Corporation (2018–2018)

Year-by-year earnings quality comparison for GenixPharmaceucticals Corporation. For live market cap and the full company financial profile, see GENX stock market capitalisation.

Year Quality Index Operating CF (CAD) Net Income YoY Change
2018 0.25x CA$34.18K CA$134.07K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.